Acadia Pharmaceuticals Inc (ACAD)

Jan 18, 2025

ACAD Seeks EU Nod for Rett Syndrome Drug, Outlines 2025 Pipeline Goals - MSN

Jan 18, 2025

Jan 17, 2025

ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Down 6.9%Time to Sell? - MarketBeat

Jan 17, 2025

Jan 17, 2025

Acadia Pharmaceuticals Awards Stock Options, RSUs to 12 New Neuroscience Talents - StockTitan

Jan 17, 2025

Jan 17, 2025

JPM25: After taking the wheel at Acadia, CEO Catherine Owen Adams looks to steer firm toward $1B in sales - FiercePharma

Jan 17, 2025

Jan 16, 2025

ACAD Seeks EU Nod for Rett Syndrome Drug, Outlines 2025 Pipeline Goals (Revised) - MSN

Jan 16, 2025

Jan 15, 2025

Burney Co. Purchases New Shares in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - MarketBeat

Jan 15, 2025

Jan 15, 2025

Neuren partner submits Rett drug for EU approval - NT News

Jan 15, 2025

Jan 14, 2025

Acadia Pharmaceuticals: Billion-Dollar Milestone and Global Expansion in 2025 - GuruFocus.com

Jan 14, 2025

Jan 14, 2025

ACADIA Pharmaceuticals (NASDAQ:ACAD) Shares Down 6.9%Time to Sell? - MarketBeat

Jan 14, 2025

Jan 14, 2025

Acadia expects more than $1B in sales for 2025 - MSN

Jan 14, 2025

Jan 14, 2025

Acadia Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Trofinetide for the Treatment of Rett Syndrome - Agenzia ANSA

Jan 14, 2025

Jan 14, 2025

Acadia seeks EMA nod for first Rett syndrome therapy - Investing.com India

Jan 14, 2025

Jan 14, 2025

Acadia Pharmaceuticals Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference - The Bakersfield Californian

Jan 14, 2025

Jan 14, 2025

Acadia Pharma (ACAD) Submits Marketing Authorization Application to the EMA for Trofinetide for the Treatment of Rett Syndrome - StreetInsider.com

Jan 14, 2025

Jan 14, 2025

Acadia Seeks EU Approval for Breakthrough Rett Syndrome Drug Trofinetide After Phase 3 Success - StockTitan

Jan 14, 2025

Jan 13, 2025

(ACAD) Proactive Strategies - Stock Traders Daily

Jan 13, 2025

Jan 12, 2025

Is ACADIA Pharmaceuticals (ACAD) the Best Medical Stock to Buy Under $20? - Insider Monkey

Jan 12, 2025

Jan 11, 2025

12 Best Medical Stocks To Buy Under $20 - Insider Monkey

Jan 11, 2025

Jan 08, 2025

Further weakness as ACADIA Pharmaceuticals (NASDAQ:ACAD) drops 5.2% this week, taking five-year losses to 61% - Yahoo Finance

Jan 08, 2025

Jan 08, 2025

Why Investors Shouldn't Be Surprised By ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) Low P/S - Simply Wall St

Jan 08, 2025

Jan 04, 2025

Acadia Pharmaceuticals downgraded to Neutral from Buy at Guggenheim - MSN

Jan 04, 2025

Jan 04, 2025

Principal Financial Group Inc. Increases Stock Position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - Defense World

Jan 04, 2025

Jan 04, 2025

ACADIA Pharmaceuticals (NASDAQ:ACAD) Downgraded to “Neutral” Rating by Guggenheim - Defense World

Jan 04, 2025

Jan 03, 2025

ACADIA Pharmaceuticals (NASDAQ:ACAD) Shares Gap DownHere's What Happened - MarketBeat

Jan 03, 2025

Jan 03, 2025

ACADIA Pharmaceuticals (NASDAQ:ACAD) Downgraded to Neutral Rating by Guggenheim - MarketBeat

Jan 03, 2025

Jan 02, 2025

Acadia (ACAD) Q2 Earnings Beat, Product Sales Drive Revenues - MSN

Jan 02, 2025

Jan 02, 2025

ACADIA Pharmaceuticals Inc.(NasdaqGS:ACAD) added to S&P 600 Health Care -January 02, 2025 - Marketscreener.com

Jan 02, 2025

Jan 02, 2025

(ACAD) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Jan 02, 2025

Jan 02, 2025

ACADIA Pharmaceuticals (NASDAQ:ACAD) Sees Unusually-High Trading VolumeHere's Why - MarketBeat

Jan 02, 2025

Jan 02, 2025

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Jan 02, 2025

Jan 02, 2025

Why ACADIA Pharmaceuticals Inc. (ACAD) Is Skyrocketing - Insider Monkey

Jan 02, 2025

Dec 31, 2024

Acadia Pharma (ACAD) 5400 contracts of February 19 calls trade - StreetInsider.com

Dec 31, 2024

Dec 31, 2024

Dow Dips Over 100 Points; Cocrystal Pharma Shares Slide - Benzinga

Dec 31, 2024

Dec 31, 2024

Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet - Benzinga

Dec 31, 2024

Dec 31, 2024

Acadia Pharmaceuticals, FTAI Aviation And Other Big Stocks Moving Higher On Tuesday - Benzinga

Dec 31, 2024

Dec 31, 2024

ACADIA Pharmaceuticals (NASDAQ:ACAD) Shares Gap UpHere's What Happened - MarketBeat

Dec 31, 2024

Dec 31, 2024

Acadia Pharmaceuticals Shares Rise With Co to Join S&P SmallCap 600 - MarketWatch

Dec 31, 2024

Dec 31, 2024

Here's Why Acadia Pharmaceuticals (ACAD) is a Strong Momentum Stock - Yahoo Finance

Dec 31, 2024

Dec 31, 2024

Short Interest in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Decreases By 5.5% - Defense World

Dec 31, 2024

Dec 31, 2024

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Sees Large Decrease in Short Interest - MarketBeat

Dec 31, 2024

Dec 30, 2024

Acadia Pharma (ACAD) to Join S&P SmallCap 600 - StreetInsider.com

Dec 30, 2024

Dec 30, 2024

Acadia Pharmaceuticals Set to Join S&P SmallCap 600 - Yahoo Finance

Dec 30, 2024

Dec 24, 2024

3 Specialty Pharma Stocks Addressing Unmet Medical Needs - Inkl

Dec 24, 2024

Dec 24, 2024

NBIX: 3 Specialty Pharma Stocks Addressing Unmet Medical Needs - StockNews.com

Dec 24, 2024

Dec 24, 2024

Acadia presents preclinical characterization of ACP-204 - BioWorld Online

Dec 24, 2024

Dec 24, 2024

Geode Capital Management LLC Has $44.23 Million Position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - MarketBeat

Dec 24, 2024